Beijing, China

Huabin He

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Agrobiological Sciences. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huabin He. Retrieved from https://idiyas.com/inventor/huabin-he

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huabin He - Innovator in Immune Response Enhancement

Introduction

Huabin He is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology through his innovative research and patent developments. His work focuses on enhancing immune responses, which is crucial for advancing therapeutic strategies.

Latest Patents

Huabin He holds a patent for a pharmaceutical composition that promotes immune responses. This composition comprises a 1-ADP-heptose conjugate and may include an immunogen or an immune checkpoint inhibitor. The application of this patent is aimed at improving immune response mechanisms, which can have profound implications in medical treatments.

Career Highlights

He is affiliated with the National Institute of Agrobiological Sciences, where he conducts his research. His dedication to advancing scientific knowledge in immunology has positioned him as a key figure in his field. With 1 patent to his name, Huabin He continues to explore innovative solutions to complex biological challenges.

Collaborations

Some of his notable coworkers include Jingjin Ding and Wenqing Gao. Their collaborative efforts contribute to the ongoing research and development in the field of immunology.

Conclusion

Huabin He exemplifies the spirit of innovation in the realm of immune response enhancement. His contributions through patents and research are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…